Go to your personalised cancer information and support area
Learn more about the dashboardExisting My Macmillan user? Access your events and volunteer services.
Information about palbociclib (Ibrance), with fulvestrant, which is available through the Cancer Drugs Fund, and which may be used to treat hormone receptor-positive, HER2-negative, advanced breast cancer.